Efficacy and Safety of Stereotactic Body Radiotherapy in Oligometastatic Uterine Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
International Journal of Radiation Oncology, Biology, Physics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
EFFICACY AND SAFETY OF STEREOTACTIC BODY RADIOTHERAPY (SBRT) IN OLIGOMETASTATIC UTERINE CANCER (MITO-RT2/RAD STUDY): A LARGE, REAL-WORLD STUDY IN COLLABORATION WITH AIRO GYN, MITO and MaNGO Groups
Int. J. Radiat. Oncol. Biol. Phys 2023 May 05;[EPub Ahead of Print], G Macchia, D Pezzulla, M Campitelli, C Laliscia, A Fodor, P Bonome, L Draghini, E Ippolito, V Sanctis, M Ferioli, F Titone, V Balcet, VD Cataldo, D Russo, L Vicenzi, S Cossa, S Lucci, S Cilla, F Deodato, MA Gambacorta, G Scambia, AG Morganti, G FerrandinaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.